Europe Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Europe Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 642 | Pages: 145 | October 2018 | Region: Europe


Europe Companion Diagnostics Market was worth USD 0.91 million in 2018 and estimated to be growing at a CAGR of 20.66%, to reach USD 2.32 million by 2023 The continued expansion of companion diagnostics will also have a global module as markets in Europe will develop in a similar but not identical pattern as the US.

Companion diagnostics are an essential part of modified medicine and will likely continue to rapidly rise in number and application to disease areas. Companion diagnostics and targeted therapeutics are the pillars of personalised medicine. Aspects of genetic testing are used for testing possible abnormalities and modifying the treatment so as to make it as personalized as the disease itself.

A major driver for growth of the market will continue to be the economic reasons for drug developers to pair their products with diagnostics. Restricted regulatory barriers for drug and diagnostic combination products, which the current IVD directive classifies under the low-risk category, are accelerating market access. One of the greatest challenges to future growth in companion diagnostics is supporting the inducements of all stakeholders.

The Europe clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.

Based on geography the European market is analysed under various regions namely, Germany, U.K, Spain, Italy and France. With the increasing initiatives from government Germany is growing at the highest rate in this region.

Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Companion Diagnostics Market By Region, From 2018-2023 (USD million)
  2. Europe Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  3. Europe Oncology Market By Region, From 2018-2023 (USD million)
  4. Europe Inflammation and Autoimmune Diseases Market By Region, From 2018-2023 (USD million)
  5. Europe Cardiovascular Diseases Market By Region, From 2018-2023 (USD million)
  6. Europe Central Nervous System Disorders Market By Region, From 2018-2023 (USD million)
  7. Europe Virology Diseases Market By Region, From 2018-2023 (USD million)
  8. Europe Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  9. Europe Immuno Histochemistry Market By Region, From 2018-2023 (USD million)
  10. Europe Molecular Diagnostics Market By Region, From 2018-2023 (USD million)
  11. Europe Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  12. Europe Colorectal Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  13. Europe Breast Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  14. Europe Lung Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  15. Europe Gastric Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  16. Europe Melanoma Diagnostics Market By Region, From 2018-2023 (USD million)
  17. Europe Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  18. Europe In-Situ Hybridization Market By Region, From 2018-2023 (USD million)
  19. Europe Real Time PCR Market By Region, From 2018-2023 (USD million)
  20. Europe Gene Sequencing Market By Region, From 2018-2023 (USD million)
  21. U.K Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  22. U.K Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  23. U.K Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  24. U.K Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  25. Spain Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  26. Spain Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  27. Spain Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  28. Spain Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  29. Germany Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  30. Germany Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  31. Germany Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  32. Germany Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  33. Italy Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  34. Italy Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  35. Italy Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  36. Italy Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  37. France Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  38. France Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  39. France Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  40. France Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
Middle East And Africa Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Ov...
Latin America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Asia-pacific Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive B...
Europe Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder...
North America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder) And B...
Middle East And Africa Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Lab...
Latin America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories...
Asia-Pacific Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories,...
Europe Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories, Refer...
North-America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (Culture-based, PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospit...
Blood Culture Tests Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-202...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.